Simultaneous determination of amodiaquine and pioglitazone on dried blood spots (DBS) by HPLC–DAD and its usefulness in pharmacokinetic studies

A simple and rapid method for simultaneous determination of amodiaquine and pioglitazone in dried blood spots (DBS) was developed and validated. Blood samples were spotted on protein saver cards and dried and a 4-mm punch was extracted with methanol first and later with 1% acetic acid and dichloromethane. The separation was achieved on a C8 Zorbax Eclipse XDB analytical column (4?µm, 150?×?4.6?mm² i.d.) at 27°C with a mobile phase of methanol/0.2% acetic acid (60:40) at a flow rate of 0.8?mL/min and detected at 230?nm. The method was linear over the range 2–80?ng/mL for amodiaquine and 10–1500?ng/mL for pioglitazone with correlation coefficients greater than 0.9995. The limits of detection were 1.12 and 10.93?µg/L and the limits of quantification were 3.39 and 33.11?µg/L for amodiaquine and pioglitazone, respectively. The inter- and intra-day precision were <6.7 and <7% for amodiaquine and <6.3 and <3% for pioglitazone. The method was applied to estimate the pharmacokinetic (PK) parameters in four healthy volunteers and it was found to yield identical PK profiles with other earlier methods supporting the use of DBS as an alternative for PK study.     

中红外无创血糖研究进展并论角质层影响

在介绍中红外无创血糖研究进展的基础上,实验探讨了组织液渗透到手指皮肤表面时,角质层对血糖测量的影响.加入角质层干扰信息前,用偏最小二乘法(PLSR)建立了模拟组织液中葡萄糖定标模型,其内部交叉验证均方差(RMSECV)为9.6 mg/dL;加入三个志愿者手指皮肤吸收的干扰信息后,所得三个模型的RMSECV分别为17.4...